Ocean Biomedical, Inc.
OCEA · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q1 2025
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Kathuria Chirinjeev: Form 4
Insider disclosure · Filed · Report period 02 Oct 2023
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001869974 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- OCEA on OTC
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 515 Madison Ave Suite 8078, New York, NY, 10022
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Ocean Biomedical, Inc./DE (to 15 Feb 2023), Aesther Healthcare Acquisition Corp. (to 14 Feb 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields